HSD17B12 anticorps (AA 40-181)
-
- Antigène Voir toutes HSD17B12 Anticorps
- HSD17B12 (Hydroxysteroid (17-Beta) Dehydrogenase 12 (HSD17B12))
-
Épitope
- AA 40-181
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HSD17B12 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human Very-long-chain 3-oxoacyl-CoA reductase protein (40-181AA)
- Isotype
- IgG
- Top Product
- Discover our top product HSD17B12 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- HSD17B12 (Hydroxysteroid (17-Beta) Dehydrogenase 12 (HSD17B12))
- Autre désignation
- HSD17B12 (HSD17B12 Produits)
- Synonymes
- anticorps KAR, anticorps SDR12C1, anticorps 2610510O05Rik, anticorps AI172963, anticorps KIK-I, anticorps Kik1, anticorps HSD17B12, anticorps kar, anticorps sdr12c1, anticorps 17-beta-HSD 12-A, anticorps fi06g11, anticorps wu:fi06g11, anticorps zf3.1, anticorps zfHSD17B12A, anticorps zgc:55589, anticorps zgc:77599, anticorps hydroxysteroid 17-beta dehydrogenase 12, anticorps hydroxysteroid (17-beta) dehydrogenase 12, anticorps hydroxysteroid (17-beta) dehydrogenase 12 L homeolog, anticorps hydroxysteroid (17-beta) dehydrogenase 12a, anticorps HSD17B12, anticorps Hsd17b12, anticorps hsd17b12.L, anticorps hsd17b12a
- Sujet
-
Background: Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate to the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation.
Aliases: 12,3-ketoacyl-CoA reductase,short chain antibody, 17 beta HSD 12 antibody, 17 beta hydroxysteroid dehydrogenase 12 antibody, 17-@beta-HSD XII antibody, 17-@beta-hydroxysteroid dehydrogenase XII antibody, 17-beta-HSD 12 antibody, 17-beta-hydroxysteroid dehydrogenase 12 antibody, 17beta HSD type 12 antibody, 3 ketoacyl CoA reductase antibody, 3-ketoacyl-CoA reductase antibody, DHB12_HUMAN antibody, Estradiol 17 beta dehydrogenase 12 antibody, Estradiol 17-beta-dehydrogenase 12 antibody, HSD17B12 antibody, Hydroxysteroid (17-beta) dehydrogenase 12 antibody, KAR antibody, KIK-I antibody, Kik1 antibody, SDR12C1 antibody, Short chain dehydrogenase/reductase family 12C member 1 antibody, Steroid dehydrogenase homolog antibody
- UniProt
- Q53GQ0
- Pathways
- Steroid Hormone Biosynthesis
-